High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maraviroc
Crossref DOI link: https://doi.org/10.1007/s00401-015-1391-6
Published Online: 2015-01-22
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stork, Lidia
Brück, Wolfgang
Bar-Or, Amit
Metz, Imke
Text and Data Mining valid from 2015-01-22